{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:19:29Z","timestamp":1785226769837,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81571664, 81871323, 81801665"],"award-info":[{"award-number":["81571664, 81871323, 81801665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of Guangdong Province","award":["2018B030311024"],"award-info":[{"award-number":["2018B030311024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5844-5","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T10:08:54Z","timestamp":1563185334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3\u2009months of age"],"prefix":"10.1186","volume":"19","author":[{"given":"Qiuying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-382X","authenticated-orcid":false,"given":"Shuixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"issue":"3","key":"5844_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/ICU.0b013e328338676a","volume":"21","author":"CL Shields","year":"2010","unstructured":"Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203\u201312.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"5844_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaophthalmol.2013.8001","volume":"132","author":"JR Wong","year":"2014","unstructured":"Wong JR, Tucker MA, Kleinerman RA, Devesa SS. Retinoblastoma incidence patterns in the US surveillance, epidemiology, and end results program. JAMA ophthalmology. 2014;132(4):478\u201383.","journal-title":"JAMA ophthalmology"},{"issue":"6","key":"5844_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/archopht.120.6.738","volume":"120","author":"DH Abramson","year":"2002","unstructured":"Abramson DH, Du TT, Beaverson KL. (Neonatal) retinoblastoma in the first month of life. Arch Ophthalmol. 2002;120(6):738\u201342.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"5844_CR4","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/archopht.122.9.1316","volume":"122","author":"DH Abramson","year":"2004","unstructured":"Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004;122(9):1316\u201323.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"5844_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0161-6420(98)94006-4","volume":"105","author":"DH Abramson","year":"1998","unstructured":"Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma. Ophthalmology. 1998;105(4):573\u201380.","journal-title":"Ophthalmology."},{"issue":"2","key":"5844_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/107327481602300203","volume":"23","author":"PR Mendoza","year":"2016","unstructured":"Mendoza PR, Grossniklaus HE. Therapeutic options for retinoblastoma. Cancer Control. 2016;23(2):99\u2013109.","journal-title":"Cancer Control"},{"issue":"1","key":"5844_CR7","doi-asserted-by":"publisher","first-page":"e0146582","DOI":"10.1371\/journal.pone.0146582","volume":"11","author":"DH Abramson","year":"2016","unstructured":"Abramson DH, Daniels AB, Marr BP, et al. Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma. PLoS One. 2016;11(1):e0146582.","journal-title":"PLoS One"},{"issue":"7","key":"5844_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","volume":"121","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. 2014;121(7):1453\u201360.","journal-title":"Ophthalmology."},{"issue":"4","key":"5844_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","volume":"96","author":"DH Abramson","year":"2012","unstructured":"Abramson DH, Marr BP, Dunkel IJ, et al. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results. Br J Ophthalmol. 2012;96(4):499\u2013502.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"5844_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","volume":"129","author":"CL Shields","year":"2011","unstructured":"Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399\u2013406.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"5844_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ophtha.2012.08.023","volume":"120","author":"DH Abramson","year":"2013","unstructured":"Abramson DH, Francis JH, Dunkel IJ, Marr BP, Brodie SE, Gobin YP. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors. Ophthalmology. 2013;120(3):560\u20135.","journal-title":"Ophthalmology."},{"issue":"8","key":"5844_CR12","doi-asserted-by":"publisher","first-page":"e0160873","DOI":"10.1371\/journal.pone.0160873","volume":"11","author":"M Chen","year":"2016","unstructured":"Chen M, Zhao J, Xia J, et al. Intra-arterial chemotherapy as primary therapy for retinoblastoma in infants less than 3 months of age: a series of 10 case-studies. PLoS One. 2016;11(8):e0160873.","journal-title":"PLoS One"},{"issue":"2","key":"5844_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","volume":"9","author":"T Yamane","year":"2004","unstructured":"Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69\u201373.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"5844_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/ICB.0000000000000279","volume":"11","author":"T Magan","year":"2017","unstructured":"Magan T, Khoo CT, Jabbour PM, Shields CL. INTRAARTERIAL chemotherapy for retinoblastoma in a 2-month-old infant. Retinal Cases Brief Reports. 2017;11(1):24\u20136.","journal-title":"Retinal Cases Brief Reports"},{"issue":"1","key":"5844_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","volume":"18","author":"A Linn Murphree","year":"2005","unstructured":"Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18(1):41\u201353 viii.","journal-title":"Ophthalmol Clin N Am"},{"issue":"9824","key":"5844_CR16","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","volume":"379","author":"H Dimaras","year":"2012","unstructured":"Dimaras H, Kimani K, Dimba EAO, et al. Retinoblastoma. Lancet. 2012;379(9824):1436\u201346.","journal-title":"Lancet"},{"issue":"9","key":"5844_CR17","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/archopht.1983.01040020364004","volume":"101","author":"DH Abramson","year":"1983","unstructured":"Abramson DH, Notterman RB, Ellsworth RM, Kitchin FD. Retinoblastoma treated in infants in the first six months of life. Arch Ophthalmol. 1983;101(9):1362\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"5844_CR18","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archophthalmol.2011.289","volume":"129","author":"S Kaliki","year":"2011","unstructured":"Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011;129(11):1422\u20137.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"5844_CR19","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","volume":"118","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081\u20137.","journal-title":"Ophthalmology."},{"issue":"7","key":"5844_CR20","doi-asserted-by":"publisher","first-page":"e644","DOI":"10.1111\/aos.13077","volume":"94","author":"S Tuncer","year":"2016","unstructured":"Tuncer S, Sencer S, Kebudi R, Tanyildiz B, Cebeci Z, Aydin K. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Acta Ophthalmol. 2016;94(7):e644\u201351.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"5844_CR21","doi-asserted-by":"publisher","first-page":"e0145436","DOI":"10.1371\/journal.pone.0145436","volume":"10","author":"DH Abramson","year":"2015","unstructured":"Abramson DH, Fabius AW, Issa R, et al. Advanced unilateral retinoblastoma: the impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC. PLoS One. 2015;10(12):e0145436.","journal-title":"PLoS One"},{"issue":"11","key":"5844_CR22","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ophtha.2018.05.013","volume":"125","author":"LA Dalvin","year":"2018","unstructured":"Dalvin LA, Ancona-Lezama D, Lucio-Alvarez JA, Masoomian B, Jabbour P, Shields CL. Ophthalmic vascular events after primary unilateral intra-arterial chemotherapy for retinoblastoma in early and recent eras. Ophthalmology. 2018;125(11):1803\u201311.","journal-title":"Ophthalmology."},{"issue":"11","key":"5844_CR23","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.ophtha.2018.08.020","volume":"125","author":"ME Aronow","year":"2018","unstructured":"Aronow ME. Intra-arterial chemotherapy for retinoblastoma: experience matters but risks remain. Ophthalmology. 2018;125(11):1812.","journal-title":"Ophthalmology."},{"issue":"6","key":"5844_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","volume":"129","author":"YP Gobin","year":"2011","unstructured":"Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129(6):732\u20137.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"5844_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjo.80.10.918","volume":"80","author":"HC Fledelius","year":"1996","unstructured":"Fledelius HC, Christensen AC. Reappraisal of the human ocular growth curve in fetal life, infancy, and early childhood. Br J Ophthalmol. 1996;80(10):918\u201321.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"5844_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archophthalmol.2010.7","volume":"128","author":"DH Abramson","year":"2010","unstructured":"Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010;128(3):370\u20132.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"5844_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/13816819209105167","volume":"13","author":"DH Abramson","year":"1992","unstructured":"Abramson DH, Servodidio CA. Retinoblastoma in the first year of life. Ophthalmic Paediatrics Genetics. 1992;13(4):191\u2013203.","journal-title":"Ophthalmic Paediatrics Genetics"},{"issue":"11","key":"5844_CR28","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1136\/bjophthalmol-2013-303694","volume":"97","author":"M Tsimpida","year":"2013","unstructured":"Tsimpida M, Thompson DA, Liasis A, et al. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision. Br J Ophthalmol. 2013;97(11):1464\u201370.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5844-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:07:39Z","timestamp":1594667259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5844-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5844"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5844-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736207095.793585156","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"9 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the institutional review board of the First Affiliated Hospital of Jinan University. Informed consent from patients was exempted due to the retrospective nature of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"693"}}